These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 18066031)

  • 1. Hepatitis C: staying the course.
    Garber K
    Nat Biotechnol; 2007 Dec; 25(12):1379-81. PubMed ID: 18066031
    [No Abstract]   [Full Text] [Related]  

  • 2. The future of vaccines--cancer meets infectious diseases: cancer vaccines and emerging vaccines. 10-13 April 2003, Semmering, Austria.
    Ulmer JB
    IDrugs; 2003 Jun; 6(6):525-6. PubMed ID: 12861987
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hepatitis B and C: From molecular virology to new antiviral therapies (part 1)].
    Thimme R; Heim M; Baumert TF; Nassal M; Moradpour D
    Dtsch Med Wochenschr; 2014 Mar; 139(13):655-9. PubMed ID: 24648178
    [No Abstract]   [Full Text] [Related]  

  • 4. Hepatitis C vaccine approaches phase II trial.
    McNeil C
    J Natl Cancer Inst; 2006 Mar; 98(5):301-2. PubMed ID: 16507825
    [No Abstract]   [Full Text] [Related]  

  • 5. Statement on hepatitis vaccines for travellers. An Advisory Committee Statement (ACS).
    Committee to Advise on Tropical Medicine and Travel (CATMAT)
    Can Commun Dis Rep; 2008 Jul; 34(ACS-2):1-24. PubMed ID: 18802989
    [No Abstract]   [Full Text] [Related]  

  • 6. Vaccination against hepatitis B and C: towards therapeutic application.
    Inchauspe G; Bach G; Martin P; Bonnefoy JY
    Int Rev Immunol; 2009; 28(1):7-19. PubMed ID: 19241251
    [No Abstract]   [Full Text] [Related]  

  • 7. Is personalized medicine finally arriving?
    Allison M
    Nat Biotechnol; 2008 May; 26(5):509-17. PubMed ID: 18464779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic vaccination for hepatitis C: can protective T-cell responses be restored after prolonged antigen exposure?
    Ferrari C
    Gastroenterology; 2008 May; 134(5):1601-4. PubMed ID: 18471527
    [No Abstract]   [Full Text] [Related]  

  • 9. Challenges and opportunities in biotechnology.
    Overby LR
    Prog Clin Biol Res; 1985; 182():425-43. PubMed ID: 2994109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C and hepatitis E vaccines: research update.
    Locarnini S
    Med J Malaysia; 2005 Jul; 60 Suppl B():116-24. PubMed ID: 16108191
    [No Abstract]   [Full Text] [Related]  

  • 11. Reality check for device-drug convergence.
    Ratner M
    Nat Biotechnol; 2007 Feb; 25(2):157-9. PubMed ID: 17287739
    [No Abstract]   [Full Text] [Related]  

  • 12. [Review of recent research on hepatitis C therapy for 54th annual meeting of the American association for the study of liver diseases].
    Wei L
    Zhonghua Gan Zang Bing Za Zhi; 2004 Feb; 12(2):118-20. PubMed ID: 14980127
    [No Abstract]   [Full Text] [Related]  

  • 13. A new formula for finding drugs.
    Davies N; Peakman T; Arlington S
    Drug Discov Today; 2004 Mar; 9(5):197-9. PubMed ID: 14980535
    [No Abstract]   [Full Text] [Related]  

  • 14. Modern Drug Discovery and Development--GTCbio's Third Annual Summit. Drug-Delivery Technology. 28-30 November 2007, San Francisco, CA, USA.
    Lee RJ
    IDrugs; 2008 Feb; 11(2):101-4. PubMed ID: 18240093
    [No Abstract]   [Full Text] [Related]  

  • 15. New Merck and Vertex drugs raise standard of care in hepatitis C.
    Sheridan C
    Nat Biotechnol; 2011 Jul; 29(7):553-4. PubMed ID: 21747363
    [No Abstract]   [Full Text] [Related]  

  • 16. Next generation flu vaccine boosted by Chiron debacle.
    Sheridan C
    Nat Biotechnol; 2004 Dec; 22(12):1487-8. PubMed ID: 15583640
    [No Abstract]   [Full Text] [Related]  

  • 17. Vaccines--why the US government must act.
    Miller HI
    Nat Biotechnol; 2005 Mar; 23(3):287. PubMed ID: 15765077
    [No Abstract]   [Full Text] [Related]  

  • 18. [S3 guideline hepatitis C addendum].
    Sarrazin C; Berg T; Buggisch P; Dollinger MM; Hinrichsen H; Hofer H; Hüppe D; Manns MP; Mauss S; Petersen J; Simon KG; van Thiel I; Wedemeyer H; Zeuzem S
    Z Gastroenterol; 2015 Apr; 53(4):320-34. PubMed ID: 25867048
    [No Abstract]   [Full Text] [Related]  

  • 19. The newest stage in the evolution of drug development.
    Ross JS
    Drug News Perspect; 2009; 22(1):59. PubMed ID: 19338121
    [No Abstract]   [Full Text] [Related]  

  • 20. Cost-effectiveness analysis of a hypothetical hepatitis C vaccine compared to antiviral therapy.
    Massad E; Coutinho FA; Chaib E; Burattini MN
    Epidemiol Infect; 2009 Feb; 137(2):241-9. PubMed ID: 18631422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.